China IPO Stages Stellar Hong Kong Debut Amid Biotech Craze

(Bloomberg) -- A Chinese medical devices provider surged 74% in its Hong Kong trading debut on Friday in the best opening performance this year for an initial public offering over $50 million.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.